← All companies

IRON

Disc Medicine, Inc.

IRON Nasdaq Pharmaceutical Preparations EDGAR ↗

$76.31

-2.90 -3.66%

Key statistics

from XBRL data in SEC filings

Market cap

$2.93B

Revenue (TTM)

—

Net income (TTM)

-$246M

EPS (TTM)

$-6.60

P/E ratio

—

Dividend yield

—

Free cash flow

-$181M

Cash

$98.7M

Total assets

$735M

Gross margin

—

52-week range

$40.00 – $99.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jun 30, 2026 8-K Shareholder vote results Jun 24, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Exit or disposal costs Feb 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure Feb 17, 2026 8-K Regulation FD disclosure; Other events Feb 13, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Other events Dec 8, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Entered a material agreement; Other events Oct 22, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Oct 20, 2025 8-K Other events Oct 17, 2025 8-K Director or officer change Oct 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change Jul 14, 2025 8-K Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Entered a material agreement; Other events Jan 24, 2025 8-K Regulation FD disclosure; Other events Jan 21, 2025 8-K Regulation FD disclosure; Other events Jan 10, 2025 8-K Other events Dec 9, 2024 8-K Entered a material agreement; Terminated a material agreement Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Nov 8, 2024 8-K Regulation FD disclosure; Other events Nov 4, 2024 8-K Regulation FD disclosure; Other events Oct 25, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Jun 14, 2024